1 922 135 EFFECTIVENESS OF YOGA FOR HYPERTENSION: SYSTEMATIC REVIEW AND META-ANALYSIS. OBJECTIVES. TO SYSTEMATICALLY REVIEW AND META-ANALYZE THE EFFECTIVENESS OF YOGA FOR REDUCING BLOOD PRESSURE IN ADULTS WITH HYPERTENSION AND TO ASSESS THE MODIFYING INFLUENCES OF TYPE AND LENGTH OF YOGA INTERVENTION AND TYPE OF COMPARISON GROUP. METHODS. ACADEMIC SEARCH PREMIER, ALTHEALTHWATCH, BIOSIS/BIOLOGICAL ABSTRACTS, CINAHL, COCHRANE LIBRARY, EMBASE, MEDLINE, PSYCINFO, PSYCARTICLES, NATURAL STANDARD, AND WEB OF SCIENCE DATABASES WERE SCREENED FOR CONTROLLED STUDIES FROM 1966 TO MARCH 2013. TWO AUTHORS INDEPENDENTLY ASSESSED RISK OF BIAS USING THE COCHRANE RISK OF BIAS TOOL. RESULTS. ALL 17 STUDIES INCLUDED IN THE REVIEW HAD UNCLEAR OR HIGH RISK OF BIAS. YOGA HAD A MODEST BUT SIGNIFICANT EFFECT ON SYSTOLIC BLOOD PRESSURE (SBP) (-4.17 [-6.35, -1.99], P = 0.0002) AND DIASTOLIC BLOOD PRESSURE (DBP) (-3.62 [-4.92, -1.60], P = 0.0001). SUBGROUP ANALYSES DEMONSTRATED SIGNIFICANT REDUCTIONS IN BLOOD PRESSURE FOR (1) INTERVENTIONS INCORPORATING 3 BASIC ELEMENTS OF YOGA PRACTICE (POSTURES, MEDITATION, AND BREATHING) (SBP: -8.17 MMHG [-12.45, -3.89]; DBP: -6.14 MMHG [-9.39, -2.89]) BUT NOT FOR MORE LIMITED YOGA INTERVENTIONS; (2) YOGA COMPARED TO NO TREATMENT (SBP: -7.96 MMHG [-10.65, -5.27]) BUT NOT FOR EXERCISE. CONCLUSION. YOGA CAN BE PRELIMINARILY RECOMMENDED AS AN EFFECTIVE INTERVENTION FOR REDUCING BLOOD PRESSURE. ADDITIONAL RIGOROUS CONTROLLED TRIALS ARE WARRANTED TO FURTHER INVESTIGATE THE POTENTIAL BENEFITS OF YOGA. 2013 2 221 49 A SYSTEMATIC REVIEW AND META-ANALYSIS OF YOGA FOR HYPERTENSION. BACKGROUND: THE AIM OF THIS SYSTEMATIC REVIEW AND META-ANALYSIS WAS TO EVALUATE THE QUALITY OF EVIDENCE AND THE STRENGTH OF RECOMMENDATION FOR YOGA AS A THERAPEUTIC MEANS IN THE MANAGEMENT OF PREHYPERTENSION AND HYPERTENSION. METHODS: MEDLINE/PUBMED, SCOPUS, CENTRAL, AND INDMED WERE SCREENED THROUGH FEBRUARY 2014 FOR RANDOMIZED CONTROLLED TRIALS (RCTS) ON THE EFFECTS OF YOGA INTERVENTIONS (>/=8 WEEKS) COMPARED WITH USUAL CARE OR ANY ACTIVE CONTROL INTERVENTION ON BLOOD PRESSURE IN PATIENTS WITH PREHYPERTENSION (120-139/80-89 MM HG) OR HYPERTENSION (>/=140/>/=90 MM HG). RISK OF BIAS WAS ASSESSED USING THE COCHRANE RISK OF BIAS TOOL; QUALITY OF EVIDENCE WAS ASSESSED ACCORDING TO THE GRADE RECOMMENDATIONS. RESULTS: SEVEN RCTS WITH A TOTAL OF 452 PATIENTS WERE INCLUDED. COMPARED WITH USUAL CARE, VERY LOW-QUALITY EVIDENCE WAS FOUND FOR EFFECTS OF YOGA ON SYSTOLIC (6 RCTS, N = 278; MEAN DIFFERENCE (MD) = -9.65 MM HG, 95% CONFIDENCE INTERVAL (CI) = -17.23 TO -2.06, P = 0.01; HETEROGENEITY: I (2) = 90%, CHI(2) = 48.21, P < 0.01) AND DIASTOLIC BLOOD PRESSURE (6 RCTS, N = 278; MD = -7.22 MM HG, 95% CI = -12.83 TO -1.62, P = 0.01; HETEROGENEITY: I (2) = 92%, CHI(2) = 64.84, P < 0.01). SUBGROUP ANALYSES REVEALED EFFECTS FOR RCTS THAT INCLUDED HYPERTENSIVE PATIENTS BUT NOT FOR RCTS THAT INCLUDED BOTH HYPERTENSIVE AND PREHYPERTENSIVE PATIENTS, AS WELL AS FOR RCTS THAT ALLOWED ANTIHYPERTENSIVE COMEDICATION BUT NOT FOR THOSE THAT DID NOT. MORE ADVERSE EVENTS OCCURRED DURING YOGA THAN DURING USUAL CARE. COMPARED WITH EXERCISE, NO EVIDENCE WAS FOUND FOR EFFECTS OF YOGA ON SYSTOLIC OR DIASTOLIC BLOOD PRESSURE. CONCLUSIONS: LARGER STUDIES ARE REQUIRED TO CONFIRM THE EMERGING BUT LOW-QUALITY EVIDENCE THAT YOGA MAY BE A USEFUL ADJUNCT INTERVENTION IN THE MANAGEMENT OF HYPERTENSION. 2014 3 2161 40 THE EFFECTS OF YOGA AMONG ADULTS WITH TYPE 2 DIABETES: A SYSTEMATIC REVIEW AND META-ANALYSIS. THE PURPOSE OF THIS META-ANALYSIS WAS TO EXAMINE THE EFFECTS OF YOGA FOR GLYCEMIC CONTROL AMONG ADULTS WITH TYPE 2 DIABETES (T2DM). COMPREHENSIVE ELECTRONIC DATABASES SEARCHES LOCATED 2559 UNIQUE STUDIES WITH RELEVANT KEY TERMS. STUDIES WERE INCLUDED IF THEY (1) EVALUATED A YOGA INTERVENTION TO PROMOTE T2DM MANAGEMENT, (2) USED A COMPARISON GROUP, (3) REPORTED AN OBJECTIVE MEASURE OF GLYCEMIC CONTROL AT POST-INTERVENTION, AND (4) HAD FOLLOW-UP LENGTH OR POST-TEST OF AT LEAST 8WEEKS FROM BASELINE. INDEPENDENT RATERS CODED PARTICIPANT, DESIGN AND METHODOLOGICAL CHARACTERISTICS AND INTERVENTION CONTENT. SUMMARY EFFECT SIZES AND 95% CONFIDENCE INTERVALS (CI) WERE CALCULATED. TWENTY-THREE STUDIES WITH 2473 PARTICIPANTS (MEAN AGE=53YEARS; 43% WOMEN) MET ELIGIBILITY CRITERIA. COMPARED WITH CONTROLS, YOGA PARTICIPANTS WERE SUCCESSFUL IN IMPROVING THEIR HBA1C (D+=0.36, 95% CI=0.16, 0.56; K=16), FBG (D+=0.58, 95% CI=0.40, 0.76; K=20), AND PPBG (D+=0.40, 95% CI=0.23, 0.56; K=14). YOGA WAS ALSO ASSOCIATED WITH SIGNIFICANT IMPROVEMENTS IN LIPID PROFILE, BLOOD PRESSURE, BODY MASS INDEX, WAIST/HIP RATIO AND CORTISOL LEVELS. OVERALL, STUDIES SATISFIED AN AVERAGE OF 41% OF THE METHODOLOGICAL QUALITY (MQ) CRITERIA; MQ SCORE WAS NOT ASSOCIATED WITH ANY OUTCOME (PS >0.05). YOGA IMPROVED GLYCEMIC OUTCOMES AND OTHER RISK FACTORS FOR COMPLICATIONS IN ADULTS WITH T2DM RELATIVE TO A CONTROL CONDITION. ADDITIONAL STUDIES WITH LONGER FOLLOW-UPS ARE NEEDED TO DETERMINE THE LONG-TERM EFFICACY OF YOGA FOR ADULTS WITH T2DM. 2017 4 2178 35 THE EFFECTS OF YOGA ON PAIN, MOBILITY, AND QUALITY OF LIFE IN PATIENTS WITH KNEE OSTEOARTHRITIS: A SYSTEMATIC REVIEW. OBJECTIVE. TO SYSTEMATICALLY ASSESS THE EFFECTS OF YOGA ON PAIN, MOBILITY, AND QUALITY OF LIFE IN PATIENTS WITH KNEE OSTEOARTHRITIS. METHODS. PUBMED, MEDLINE, EMBASE, THE COCHRANE CENTRAL REGISTER OF CONTROLLED TRIALS, PHYSIOTHERAPY EVIDENCE DATABASE (PEDRO), AND OTHER SOURCES WERE SEARCHED SYSTEMATICALLY IN THIS STUDY. TWO REVIEWERS IDENTIFIED ELIGIBLE STUDIES AND EXTRACTED DATA INDEPENDENTLY. DOWNS AND BLACK'S QUALITY INDEX WERE USED TO EVALUATE THE METHODOLOGICAL QUALITY OF THE INCLUDED STUDIES. RESULTS. A TOTAL OF 9 ARTICLES (6 STUDIES) INVOLVING 372 PATIENTS WITH KNEE OSTEOARTHRITIS MET THE INCLUSION CRITERIA. THE MOST COMMON YOGA PROTOCOL IS 40~90 MINUTES/SESSION, LASTING FOR AT LEAST 8 WEEKS. THE EFFECT OF YOGA ON PAIN RELIEF AND FUNCTION IMPROVEMENT COULD BE SEEN AFTER TWO-WEEK INTERVENTION. CONCLUSION. THIS SYSTEMATIC REVIEW SHOWED THAT YOGA MIGHT HAVE POSITIVE EFFECTS IN RELIEVING PAIN AND MOBILITY ON PATIENTS WITH KOA, BUT THE EFFECTS ON QUALITY OF LIFE (QOL) ARE UNCLEAR. BESIDES, MORE OUTCOME MEASURE RELATED TO MENTAL HEALTH OF YOGA EFFECTS ON PEOPLE WITH KOA SHOULD BE CONDUCTED. 2016 5 2491 51 YOGA AS ANTIHYPERTENSIVE LIFESTYLE THERAPY: A SYSTEMATIC REVIEW AND META-ANALYSIS. OBJECTIVE: TO INVESTIGATE THE EFFICACY OF YOGA AS ANTIHYPERTENSIVE LIFESTYLE THERAPY AND IDENTIFY MODERATORS THAT ACCOUNT FOR VARIABILITY IN THE BLOOD PRESSURE (BP) RESPONSE TO YOGA. METHODS: WE SYSTEMATICALLY SEARCHED 6 ELECTRONIC DATABASES FROM INCEPTION THROUGH JUNE 4, 2018, FOR ARTICLES PUBLISHED IN ENGLISH LANGUAGE JOURNALS ON TRIALS OF YOGA INTERVENTIONS THAT INVOLVED ADULT PARTICIPANTS, REPORTED PREINTERVENTION AND POSTINTERVENTION BP, AND HAD A NONEXERCISE/NONDIET CONTROL GROUP. OUR SEARCH YIELDED 49 QUALIFYING CONTROLLED TRIALS (56 INTERVENTIONS). WE (1) EVALUATED THE RISK OF BIAS AND METHODOLOGICAL STUDY QUALITY, (2) PERFORMED META-REGRESSION ANALYSIS FOLLOWING RANDOM-EFFECTS ASSUMPTIONS, AND (3) GENERATED ADDITIVE MODELS THAT REPRESENTED THE LARGEST POSSIBLE CLINICALLY RELEVANT BP REDUCTIONS. RESULTS: ON AVERAGE, THE 3517 TRIAL PARTICIPANTS WERE MIDDLE-AGED (49.2+/-19.5 YEARS), OVERWEIGHT (27.9+/-3.6 KG/M(2)) ADULTS WITH HIGH BP (SYSTOLIC BP, 129.3+/-13.3 MM HG; DIASTOLIC BP, 80.7+/-8.4 MM HG). YOGA WAS PRACTICED 4.8+/-3.4 SESSIONS PER WEEK FOR 59.2+/-25.0 MINUTES PER SESSION FOR 13.2+/-7.5 WEEKS. ON AVERAGE, YOGA ELICITED MODERATE REDUCTIONS IN SYSTOLIC BP (WEIGHTED MEAN EFFECT SIZE, -0.47; 95% CI, -0.62-0.32, -5.0 MM HG) AND DIASTOLIC BP (WEIGHTED MEAN EFFECT SIZE, -0.47; 95% CI, -0.61 TO -0.32; -3.9 MM HG) COMPARED WITH CONTROLS (P<.001 FOR BOTH SYSTOLIC BP AND DIASTOLIC BP). CONTROLLING FOR PUBLICATION BIAS AND METHODOLOGICAL STUDY QUALITY, WHEN YOGA WAS PRACTICED 3 SESSIONS PER WEEK AMONG SAMPLES WITH HYPERTENSION, YOGA INTERVENTIONS THAT INCLUDED BREATHING TECHNIQUES AND MEDITATION/MENTAL RELAXATION ELICITED BP REDUCTIONS OF 11/6 MM HG COMPARED WITH THOSE THAT DID NOT (IE, 6/3 MM HG). CONCLUSION: OUR RESULTS INDICATE THAT YOGA IS A VIABLE ANTIHYPERTENSIVE LIFESTYLE THERAPY THAT PRODUCES THE GREATEST BP BENEFITS WHEN BREATHING TECHNIQUES AND MEDITATION/MENTAL RELAXATION ARE INCLUDED. 2019 6 2539 39 YOGA FOR ADULTS WITH TYPE 2 DIABETES: A SYSTEMATIC REVIEW OF CONTROLLED TRIALS. A GROWING BODY OF EVIDENCE SUGGESTS YOGIC PRACTICES MAY BENEFIT ADULTS WITH TYPE 2 DIABETES (DM2). IN THIS SYSTEMATIC REVIEW, WE EVALUATE AVAILABLE EVIDENCE FROM PROSPECTIVE CONTROLLED TRIALS REGARDING THE EFFECTS OF YOGA-BASED PROGRAMS ON SPECIFIC HEALTH OUTCOMES PERTINENT TO DM2 MANAGEMENT. TO IDENTIFY QUALIFYING STUDIES, WE SEARCHED NINE DATABASES AND SCANNED BIBLIOGRAPHIES OF RELEVANT REVIEW PAPERS AND ALL IDENTIFIED ARTICLES. CONTROLLED TRIALS THAT DID NOT TARGET ADULTS WITH DIABETES, INCLUDED ONLY ADULTS WITH TYPE 1 DIABETES, WERE UNDER TWO-WEEK DURATION, OR DID NOT INCLUDE QUANTITATIVE OUTCOME DATA WERE EXCLUDED. STUDY QUALITY WAS EVALUATED USING THE PEDRO SCALE. THIRTY-THREE PAPERS REPORTING FINDINGS FROM 25 CONTROLLED TRIALS (13 NONRANDOMIZED, 12 RANDOMIZED) MET OUR INCLUSION CRITERIA (N = 2170 PARTICIPANTS). COLLECTIVELY, FINDINGS SUGGEST THAT YOGIC PRACTICES MAY PROMOTE SIGNIFICANT IMPROVEMENTS IN SEVERAL INDICES OF IMPORTANCE IN DM2 MANAGEMENT, INCLUDING GLYCEMIC CONTROL, LIPID LEVELS, AND BODY COMPOSITION. MORE LIMITED DATA SUGGEST THAT YOGA MAY ALSO LOWER OXIDATIVE STRESS AND BLOOD PRESSURE; ENHANCE PULMONARY AND AUTONOMIC FUNCTION, MOOD, SLEEP, AND QUALITY OF LIFE; AND REDUCE MEDICATION USE IN ADULTS WITH DM2. HOWEVER, GIVEN THE METHODOLOGICAL LIMITATIONS OF EXISTING STUDIES, ADDITIONAL HIGH-QUALITY INVESTIGATIONS ARE REQUIRED TO CONFIRM AND FURTHER ELUCIDATE THE POTENTIAL BENEFITS OF YOGA PROGRAMS IN POPULATIONS WITH DM2. 2016 7 2410 33 YOGA AND HYPERTENSION: A SYSTEMATIC REVIEW. LIFESTYLE MODIFICATION IS A CORNERSTONE OF HYPERTENSION (HPT) TREATMENT, YET MOST RECOMMENDATIONS CURRENTLY FOCUS ON DIET AND EXERCISE AND DO NOT CONSIDER STRESS REDUCTION STRATEGIES. YOGA IS A SPIRITUAL PATH THAT MAY REDUCE BLOOD PRESSURE (BP) THROUGH REDUCING STRESS, INCREASING PARASYMPATHETIC ACTIVATION, AND ALTERING BARORECEPTOR SENSITIVITY; HOWEVER, DESPITE REVIEWS ON YOGA AND CARDIOVASCULAR DISEASE, DIABETES, METABOLIC SYNDROME, AND ANXIETY THAT SUGGEST YOGA MAY REDUCE BP, NO COMPREHENSIVE REVIEW HAS YET FOCUSED ON YOGA AND HPT. A SYSTEMATIC REVIEW OF ALL PUBLISHED STUDIES ON YOGA AND HPT WAS PERFORMED REVEALING 39 COHORT STUDIES, 30 NONRANDOMIZED, CONTROLLED TRIALS (NRCTS), 48 RANDOMIZED, CONTROLLED TRIALS (RCTS), AND 3 CASE REPORTS WITH DURATIONS RANGING FROM 1 WK TO 4 Y AND INVOLVING A TOTAL OF 6693 SUBJECTS. MOST STUDIES REPORTED THAT YOGA EFFECTIVELY REDUCED BP IN BOTH NORMOTENSIVE AND HYPERTENSIVE POPULATIONS. THESE STUDIES SUGGEST THAT YOGA IS AN EFFECTIVE ADJUNCT THERAPY FOR HPT AND WORTHY OF INCLUSION IN CLINICAL GUIDELINES, YET THE GREAT HETEROGENEITY OF YOGA PRACTICES AND THE VARIABLE QUALITY OF THE RESEARCH MAKES IT DIFFICULT TO RECOMMEND ANY SPECIFIC YOGA PRACTICE FOR HPT. FUTURE RESEARCH NEEDS TO FOCUS ON HIGH QUALITY CLINICAL TRIALS ALONG WITH STUDIES ON THE MECHANISMS OF ACTION OF DIFFERENT YOGA PRACTICES. 2014 8 2098 43 THE EFFECT OF YOGA INTERVENTIONS ON CANCER-RELATED FATIGUE AND QUALITY OF LIFE FOR WOMEN WITH BREAST CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS. BACKGROUND: WOMEN WITH BREAST CANCER (BC) ARE LIVING LONGER WITH DEBILITATING SIDE EFFECTS SUCH AS CANCER-RELATED FATIGUE (CRF) THAT AFFECT OVERALL WELL-BEING. YOGA PROMOTES HEALTH, WELL-BEING AND MAY BE BENEFICIAL IN REDUCING CRF. ALTHOUGH THERE HAVE BEEN PREVIOUS SYSTEMATIC REVIEWS AND META-ANALYSES, THE EFFECTS OF YOGA ON CRF AND QUALITY OF LIFE (QOL) REMAIN UNCLEAR, PARTICULARLY IN COMPARISON WITH OTHER TYPES OF PHYSICAL ACTIVITY (PA). OUR OBJECTIVE IS TO CARRY OUT A SYSTEMATIC REVIEW AND META-ANALYSIS OF THE EFFECTS OF YOGA ON CRF AND QOL IN WOMEN WITH BC. METHODS: ELECTRONIC DATABASES WERE SEARCHED (MEDLINE, EMBASE CLASSIC+EMBASE AND EMB REVIEWS, COCHRANE CENTRAL CT) FROM INCEPTION TO MAY 2018. RANDOMIZED CONTROLLED TRIALS WERE INCLUDED IF THEY WERE FULL TEXT, IN ENGLISH, INCLUDED A YOGA INTERVENTION, A COMPARATOR (INCLUDING NON-PA USUAL CARE OR ALTERNATE PA INTERVENTION), AND REPORTED ON CRF OR QOL. EFFECTS OF YOGA WERE POOLED USING STANDARDIZED MEAN DIFFERENCE (SMD) VIA A RANDOM EFFECTS MODEL. RESULTS: OF THE 2468 RECORDS RETRIEVED, 24 TRIALS WERE INCLUDED; 18 STUDIES COMPARED YOGA TO A NON-PA COMPARATOR AND 6 TO A PA COMPARATOR. YOGA DEMONSTRATED STATISTICALLY SIGNIFICANT IMPROVEMENTS IN CRF OVER NON-PA (SMD -0.30 [-0.51; -0.08]) BUT NOT PA (SMD -0.17 [-0.50; 0.17]) COMPARATORS. ADDITIONALLY, YOGA DEMONSTRATED STATISTICALLY SIGNIFICANT IMPROVEMENTS IN QOL OVER NON-PA (SMD -0.27 [-0.46; -0.07]) BUT NOT PA (SMD 0.04 [-0.22; +0.31]) COMPARATORS. DISCUSSION: THIS META-ANALYSIS FOUND THAT YOGA PROVIDES SMALL TO MEDIUM IMPROVEMENTS IN CRF AND QOL COMPARED TO NON-PA, BUT NOT IN COMPARISON TO OTHER PA INTERVENTIONS. 2020 9 856 29 EFFECT OF YOGA ON THE QUALITY OF LIFE OF PATIENTS WITH RHEUMATIC DISEASES: SYSTEMATIC REVIEW WITH META-ANALYSIS. AIM: TO ANALYZE THE EFFECTS OF YOGA ON THE QUALITY OF LIFE OF PATIENTS WITH RHEUMATIC DISEASES THROUGH A SYSTEMATIC REVIEW WITH META-ANALYSIS. METHODS: THIS SYSTEMATIC REVIEW WITH META-ANALYSIS WAS CONDUCTED FOLLOWING THE RECOMMENDATIONS OF THE DECLARATION OF PRISMA. THE SEARCHES WERE CARRIED OUT ON THE DATABASES PUBMED, WEB OF SCIENCE, EBSCO, SCOPUS, AND COCHRANE UNTIL AUGUST 2018. EXPERIMENTAL STUDIES EVALUATING THE EFFECT OF YOGA ON THE QUALITY OF LIFE IN PATIENTS WITH RHEUMATIC DISEASES WERE INCLUDED. RESULTS: AFTER DATA SEARCHES, 483 STUDIES WERE FOUND, 23 OF WHICH WERE INCLUDED IN OUR ANALYSIS. WE FOUND THAT YOGA IMPROVES THE OVERALL QUALITY OF LIFE (D= -0.64; 95% CI: -0.91 TO 0.038) OF PATIENTS WITH RHEUMATIC DISEASES, AS WELL AS THE FOLLOWING DOMAINS: FUNCTIONAL CAPACITY (D=16.43; 95% CI: 13.37-19.49), PHYSICAL ASPECTS (D=27.11; 95% CI: 19.40-34.83), EMOTIONAL ASPECTS (D=26.00; 95% CI: 18.87-33.13), GENERAL HEALTH (D=16.61; 95% CI: 12.66-20.55), AND SOCIAL ASPECTS (D=7.01 ; 95% CI: 5.57-9.45). CONCLUSION: EVIDENCE SUGGESTS WEAK RECOMMENDATIONS CAN BE MADE FOR THE USE OF YOGA IN THE MANAGEMENT OF RD PATIENTS. 2019 10 2154 36 THE EFFECTS OF THAI YOGA ON PHYSICAL FITNESS: A META-ANALYSIS OF RANDOMIZED CONTROL TRIALS. OBJECTIVES: THAI YOGA IS A TRADITIONAL THAI EXERCISE USED FOR IMPROVING HEALTH-RELATED PHYSICAL FITNESS. MANY STUDIES HAVE EVALUATED THESE EFFECTS, BUT THEIR RESULTS REMAIN INCONCLUSIVE. THIS META-ANALYSIS AIMED TO EXAMINE THE EFFECTIVENESS OF THAI YOGA ON PHYSICAL FITNESS. DESIGN/METHODS: PUBMED, EMBASE, CINAHL, COCHRANE LIBRARY, THAI LIBRARY INTEGRATED SYSTEM (THAILIS), PHYSIOTHERAPY EVIDENCE DATABASE (PEDRO), NATIONAL REHABILITATION INFORMATION CENTER (REHABDATA), SCOPUS, WEB OF SCIENCE, THAI UNIVERSITY LIBRARY DATABASES/JOURNALS, AND THAI PHYSICAL THERAPY DATABASE UP TO MARCH 2016 WERE SEARCHED FOR RANDOMIZED CONTROLLED TRIALS (RCTS) EXAMINING THE EFFECT OF THAI YOGA EXERCISE COMPARED WITH NORMAL DAILY ACTIVITIES AS CONTROLS, IN ANY LANGUAGE. THE WEIGHTED MEAN DIFFERENCE (WMD) AND 95% CONFIDENCE INTERVALS (95% CI) WERE PERFORMED USING THE RANDOM-EFFECTS MODEL. RESULTS: SEVEN RCTS MET THE INCLUSION CRITERIA. THAI YOGA TRAINING SIGNIFICANTLY IMPROVED BODY FLEXIBILITY BY 3.9 CM AFTER 4 WEEKS [95% CI = 3.9-4.0; P < 0.001: NO HETEROGENEITY CHI(2) = 0.66, D.F.2, P = 0.7; I(2) 0.00%] AND 8.9 CM AFTER 8 WEEKS [95% CI = 7.4-10.5; P < 0.001: NO HETEROGENEITY CHI(2) = 0.16, D.F.2, P = 0.9; I(2) 0.00%] COMPARED TO CONTROLS. IT ALSO SIGNIFICANTLY INCREASED RANGE OF MOTION (ROM) OF RIGHT SHOULDER EXTENSION BY 1.5 DEGREES AT WEEK 8, COMPARED TO CONTROLS [95% CI = 0.12-2.81; P = 0.03; LOW HETEROGENEITY CHI(2) = 1.61, D.F.1, P = 0.2; I(2) 37.9%]. GREATER ROM FOR RIGHT SHOULDER ABDUCTION WAS OBSERVED AFTER 12 WEEKS COMPARED TO CONTROLS [22.2 DEGREES (95% CI = 20-24; P < 0.001): NO HETEROGENEITY CHI(2) = 0.29, D.F.1, P = 0.6; I(2) 0.00%]. CONCLUSIONS: THAI YOGA EXERCISES APPEARED USEFUL, IN PARTICULAR, ON BODY AND RIGHT SHOULDER JOINT FLEXIBILITY. REGULAR STRETCHING EXERCISE OF THAI YOGA AND/OR IN COMBINATION WITH EXERCISES COULD PROMOTE HEALTH-RELATED PHYSICAL FITNESS. 2018 11 2063 48 THE BENEFITS OF YOGA PRACTICE COMPARED TO PHYSICAL EXERCISE IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS: A SYSTEMATIC REVIEW AND META-ANALYSIS. YOGA IS INCREASINGLY USED AS AN ADJUNCTIVE THERAPY IN THE MANAGEMENT OF TYPE-2 DIABETES MELLITUS (T2DM). THE PRESENT STUDY AIMS TO SYSTEMATICALLY EVALUATE THE LITERATURE AND PERFORM A META-ANALYSIS ON THE EFFECTS OF YOGA PRACTICE COMPARED TO PHYSICAL EXERCISE IN THE MANAGEMENT OF T2DM. DATA WERE OBTAINED USING A STEPWISE SEARCH PROCESS USING KEYWORDS IN THE FOLLOWING ONLINE MEDICAL DATABASES; PUBMED, WEB OF SCIENCE AND SCOPUS. ALL CONTROLLED CLINICAL TRIALS INVOLVING PATIENTS WITH T2DM, COMPARING YOGA AS AN INTERVENTION WITH PHYSICAL EXERCISE AND EVALUATING GLYCAEMIC CONTROL AND OTHER OUTCOMES BETWEEN THE INTERVENTION AND CONTROL GROUPS WERE INCLUDED IN THE ANALYSIS. EIGHT STUDIES WERE ELIGIBLE TO BE INCLUDED IN THE SYSTEMATIC REVIEW. IN TOTAL, 842 PARTICIPANTS WERE ASSIGNED TO A YOGA INTERVENTION OR A CONTROL GROUP WITH AN EXERCISE INTERVENTION AND THE AGE RANGE OF PARTICIPANTS WAS 30-78 YEARS. A SIGNIFICANT REDUCTION IN FBG (15.16MG/DL), PPBG (28.66MG/DL), HBA1C (0.39%) AND BMI (0.71KG/M2) WAS NOTED IN THE INTERVENTION GROUP ('YOGA') COMPARED TO THE CONTROL GROUP ('PHYSICAL EXERCISE') IN THE POOLED ANALYSIS. WE DID NOT OBSERVE ANY SIGNIFICANT DIFFERENCE BETWEEN THE TWO GROUPS FOR LIPID PARAMETERS, OTHER BODY COMPOSITION MEASURES (WC AND WHR) AND BLOOD PRESSURE. IN CONCLUSION, OUR RESULTS SHOW THAT YOGA HAS BENEFICIAL EFFECTS ON GLYCAEMIC CONTROL IN COMPARISON TO PHYSICAL EXERCISE IN T2DM HOWEVER, INDIVIDUAL STUDIES SHOWED CONSIDERABLE HETEROGENEITY. HENCE, FURTHER WELL-CONTROLLED RANDOMIZED TRIALS ARE REQUIRED PRIOR TO DRAWING CONCLUSIONS ABOUT THE BENEFITS OF YOGA IN COMPARISON TO PHYSICAL EXERCISE. 2018 12 2647 48 YOGA HAS A SOLID EFFECT ON CANCER-RELATED FATIGUE IN PATIENTS WITH BREAST CANCER: A META-ANALYSIS. PURPOSE: THIS STUDY WAS DESIGNED TO CRITICALLY EVALUATE THE EFFECT OF YOGA ON CANCER-RELATED FATIGUE IN PATIENTS WITH BREAST CANCER. METHODS: EIGHT DATABASES (COCHRANE LIBRARY, PUBMED, OVID-MEDLINE, WEB OF SCIENCE, CBM, WANFANG, VIP, AND CNKI) WERE SYSTEMATICALLY REVIEWED FROM INCEPTION TO JANUARY 2019 FOR RANDOMIZED CONTROLLED TRIALS (RCTS). TWO REVIEWERS CRITICALLY AND INDEPENDENTLY ASSESSED THE RISK OF BIAS USING COCHRANE COLLABORATION CRITERIA AND EXTRACTED CORRELATED DATA USING THE DESIGNED FORM. ALL ANALYSES WERE PERFORMED WITH REVIEW MANAGER 5.3. RESULTS: A TOTAL OF 17 QUALIFIED STUDIES THAT INCLUDED 2183 PATIENTS (YOGA: 1112, CONTROL: 1071) WERE INCLUDED IN THE META-ANALYSIS. YOGA HAD A LARGE EFFECT ON FATIGUE IN POST-TREATMENT BREAST CANCER PATIENTS AND HAD A SMALL EFFECT ON INTRA-TREATMENT PATIENTS. THE META-ANALYSIS ALSO INDICATED THAT SUPERVISED YOGA CLASS HAD A SIGNIFICANT EFFECT ON CRF; THE SIX-WEEK PROGRAM HAD A MODERATE BENEFICIAL EFFECT WHILE THE 60/90 MIN/SESSION SUPERVISED YOGA CLASS AND THE EIGHT-WEEK PROGRAM DEMONSTRATED A LARGE EFFECT ON FATIGUE IN PATIENTS WITH BREAST CANCER. YOGA COULD MARKEDLY MITIGATE THE PHYSICAL FATIGUE IN BREAST CANCER PATIENTS, HAD A MEDIUM IMPACT ON COGNITIVE FATIGUE, AND MANIFESTED A SMALL EFFECT ON MENTAL FATIGUE. EIGHT STUDIES REPORTED THE ADVERSE EVENTS, WHEREAS TEN STUDIES DID NOT. CONCLUSIONS: YOGA CAN BE CONSIDERED AS AN ALTERNATIVE THERAPY FOR RELIEVING FATIGUE IN BREAST CANCER PATIENTS WHO HAVE COMPLETED TREATMENT OR ARE UNDERGOING ANTI-CANCER TREATMENT. 2019 13 223 44 A SYSTEMATIC REVIEW AND META-ANALYSIS ON THE EFFECTS OF YOGA ON WEIGHT-RELATED OUTCOMES. INTRODUCTION: OVERWEIGHT AND OBESITY ARE AMONG THE MOST IMPORTANT MODIFIABLE RISK FACTORS FOR CHRONIC DISEASES AND PREMATURE DEATH. THE AIM OF THIS REVIEW WAS TO SYSTEMATICALLY ASSESS AND ANALYZE THE EFFECTS OF YOGA ON WEIGHT-RELATED OUTCOMES. METHODS: MEDLINE/PUBMED, SCOPUS, AND THE COCHRANE LIBRARY WERE SCREENED THROUGH MARCH 2015 FOR RANDOMIZED CONTROLLED TRIALS ON YOGA FOR WEIGHT-RELATED OUTCOMES IN THE GENERAL POPULATION OR OVERWEIGHT/OBESE INDIVIDUALS. RISK OF BIAS WAS ASSESSED USING THE COCHRANE RISK OF BIAS TOOL ON THE FOLLOWING DOMAINS: SELECTION BIAS, PERFORMANCE BIAS, DETECTION BIAS, ATTRITION BIAS, REPORTING BIAS, AND OTHER BIAS. RESULTS: OUT OF 445 RECORDS IDENTIFIED DURING LITERATURE SEARCH, 30 TRIALS WITH A TOTAL OF 2173 PARTICIPANTS WERE INCLUDED. NO EFFECTS ON WEIGHT, BODY MASS INDEX, BODY FAT PERCENTAGE OR WAIST CIRCUMFERENCE WERE FOUND. IN STUDIES WITH HEALTHY ADULT PARTICIPANTS AN EFFECT OF YOGA COMPARED TO USUAL CARE WAS FOUND REGARDING WAIST/HIP RATIO (SMD=--1.00; 95% CI=--1.44, -0.55; P<0.001). IN STUDIES WITH OVERWEIGHT/OBESE PARTICIPANTS ONLY, EFFECTS RELATIVE TO USUAL CARE WERE FOUND FOR BODY MASS INDEX (SMD=-0.99; 95% CI=-1.67, -0.31; P=0.004). EFFECTS HOWEVER WERE NOT ROBUST AGAINST SELECTION BIAS; AND PUBLICATION BIAS COULD NOT BE RULED OUT. NO INTERVENTION-RELATED ADVERSE EVENTS WERE REPORTED. CONCLUSIONS: DESPITE METHODOLOGICAL DRAWBACKS, YOGA CAN BE PRELIMINARILY CONSIDERED A SAFE AND EFFECTIVE INTERVENTION TO REDUCE BODY MASS INDEX IN OVERWEIGHT OR OBESE INDIVIDUALS. 2016 14 2559 39 YOGA FOR CHRONIC LOW BACK PAIN: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS. OBJECTIVES: TO EVALUATE THE EFFICACY OF YOGA AS AN INTERVENTION FOR CHRONIC LOW BACK PAIN (CLBP) USING A META-ANALYTICAL APPROACH. RANDOMIZED CONTROLLED TRIALS (RCTS) THAT EXAMINED PAIN ANDOR FUNCTIONAL DISABILITY AS TREATMENT OUTCOMES WERE INCLUDED. POST-TREATMENT AND FOLLOW-UP OUTCOMES WERE ASSESSED. METHODS: A COMPREHENSIVE SEARCH OF RELEVANT ELECTRONIC DATABASES, FROM THE TIME OF THEIR INCEPTION UNTIL NOVEMBER 2011, WAS CONDUCTED. COHEN'S D EFFECT SIZES WERE CALCULATED AND ENTERED IN A RANDOM-EFFECTS MODEL. RESULTS: EIGHT RCTS MET THE CRITERIA FOR INCLUSION (EIGHT ASSESSING FUNCTIONAL DISABILITY AND FIVE ASSESSING PAIN) AND INVOLVED A TOTAL OF 743 PATIENTS. AT POST-TREATMENT, YOGA HAD A MEDIUM TO LARGE EFFECT ON FUNCTIONAL DISABILITY (D=0.645) AND PAIN (D=0.623). DESPITE A WIDE RANGE OF YOGA STYLES AND TREATMENT DURATIONS, HETEROGENEITY IN POST-TREATMENT EFFECT SIZES WAS LOW. FOLLOW-UP EFFECT SIZES FOR FUNCTIONAL DISABILITY AND PAIN WERE SMALLER, BUT REMAINED SIGNIFICANT (D=0.397 AND D=0.486, RESPECTIVELY); HOWEVER, THERE WAS A MODERATE TO HIGH LEVEL OF VARIABILITY IN THESE EFFECT SIZES. DISCUSSION: THE RESULTS OF THE PRESENT STUDY INDICATE THAT YOGA MAY BE AN EFFICACIOUS ADJUNCTIVE TREATMENT FOR CLBP. THE STRONGEST AND MOST CONSISTENT EVIDENCE EMERGED FOR THE SHORT-TERM BENEFITS OF YOGA ON FUNCTIONAL DISABILITY. HOWEVER, BEFORE ANY DEFINITIVE CONCLUSIONS CAN BE DRAWN, THERE ARE A NUMBER OF METHODOLOGICAL CONCERNS THAT NEED TO BE ADDRESSED. IN PARTICULAR, IT IS RECOMMENDED THAT FUTURE RCTS INCLUDE AN ACTIVE CONTROL GROUP TO DETERMINE WHETHER YOGA HAS SPECIFIC TREATMENT EFFECTS AND WHETHER YOGA OFFERS ANY ADVANTAGES OVER TRADITIONAL EXERCISE PROGRAMS AND OTHER ALTERNATIVE THERAPIES FOR CLBP. 2013 15 2566 41 YOGA FOR DEPRESSION AND ANXIETY SYMPTOMS IN PEOPLE WITH CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS. OBJECTIVE: CANCER AND ITS TREATMENT CAN LEAD TO A VARIETY OF PHYSICAL AND EMOTIONAL CONCERNS IMPACTING ON THOSE AFFECTED, INCLUDING SUBCLINICAL OR CLINICAL DEPRESSION AND ANXIETY, WHICH IN TURN HAVE A SIGNIFICANT IMPACT ON WELLBEING, QUALITY OF LIFE AND SURVIVAL. THE AIM OF THIS REVIEW WAS TO EVALUATE THE EFFECT OF YOGA-BASED INTERVENTIONS ON SELF-REPORTED DEPRESSION AND ANXIETY SYMPTOMS IN PEOPLE WITH CANCER IN RANDOMIZED CONTROLLED TRIALS. METHOD: SIX DATABASES WERE SEARCHED TO IDENTIFY RELEVANT STUDIES. SYSTEMATIC REVIEW PROCEDURES WERE FOLLOWED INCLUDING A QUALITY ASSESSMENT. META-ANALYSIS OF SUITABLE STUDIES WAS CONDUCTED. RESULTS: 26 STUDIES FROM OUR SEARCH CRITERIA WERE ELIGIBLE FOR INCLUSION FOR DEPRESSIVE AND 16 FOR ANXIETY SYMPTOMS. META-ANALYSES REVEALED EVIDENCE FOR SIGNIFICANT MEDIUM EFFECTS OF YOGA ON DEPRESSION SYMPTOMS (N = 1,486, G = -0.419, 95% CONFIDENCE INTERVAL [CI] = -0.558 TO -0.281, P < 0.001) AND ANXIETY (N = 977, G = -0.347, 95% CI = -0.473 TO -0.221, P < 0.001) COMPARED TO CONTROLS. SUBGROUP ANALYSES FOR DEPRESSIVE SYMPTOMS REVEALED SIGNIFICANT EFFECTS FOR ALL ANALYSES PERFORMED (TYPE OF CANCER, TYPE OF CONTROL, TREATMENT STATUS, DURATION OF INTERVENTION OR FREQUENCY OF YOGA SESSIONS), WITH EFFECT SIZES BEING COMPARABLE BETWEEN SUBGROUPS. SIMILAR FINDINGS WERE FOUND FOR ANXIETY SYMPTOMS EXCEPT FOR TREATMENT STATUS, WHERE THE ONLY SIGNIFICANT EFFECT WAS FOUND WHEN YOGA WAS DELIVERED DURING ACTIVE TREATMENT. CONCLUSIONS: THIS REVIEW PROVIDES EVIDENCE THAT IN PEOPLE WITH CANCER, YOGA-BASED INTERVENTIONS ARE ASSOCIATED WITH AMELIORATION OF DEPRESSION AND ANXIETY SYMPTOMS AND THEREFORE A PROMISING THERAPEUTIC MODALITY FOR THEIR MANAGEMENT. HOWEVER, THE POTENTIAL FOR RISK OF BIAS TOGETHER WITH CONTROL GROUP DESIGN CHALLENGES MEANS THE RESULTS SHOULD BE INTERPRETED WITH CAUTION. 2021 16 2144 40 THE EFFECTS OF MEDITATION, YOGA, AND MINDFULNESS ON DEPRESSION, ANXIETY, AND STRESS IN TERTIARY EDUCATION STUDENTS: A META-ANALYSIS. BACKGROUND: MEDITATION, YOGA, AND MINDFULNESS ARE POPULAR INTERVENTIONS AT UNIVERSITIES AND TERTIARY EDUCATION INSTITUTES TO IMPROVE MENTAL HEALTH. HOWEVER, THE EFFECTS ON DEPRESSION, ANXIETY, AND STRESS ARE UNCLEAR. THIS STUDY ASSESSED THE EFFECTIVENESS OF MEDITATION, YOGA, AND MINDFULNESS ON SYMPTOMS OF DEPRESSION, ANXIETY, AND STRESS IN TERTIARY EDUCATION STUDENTS. METHODS: WE SEARCHED COCHRANE CENTRAL REGISTER OF CONTROLLED TRIALS (CENTRAL), PUBMED, PSYCINFO AND IDENTIFIED 11,936 ARTICLES. AFTER RETRIEVING 181 PAPERS FOR FULL-TEXT SCREENING, 24 RANDOMIZED CONTROLLED TRIALS WERE INCLUDED IN THE QUALITATIVE ANALYSIS. WE CONDUCTED A RANDOM-EFFECTS META-ANALYSIS AMONGST 23 STUDIES WITH 1,373 PARTICIPANTS. RESULTS: AT POST-TEST, AFTER EXCLUSION OF OUTLIERS, EFFECT SIZES FOR DEPRESSION, G = 0.42 (95% CI: 0.16-0.69), ANXIETY G = 0.46 (95% CI: 0.34-0.59), STRESS G = 0.42 (95% CI: 0.27-0.57) WERE MODERATE. HETEROGENEITY WAS LOW (I (2) = 6%). WHEN COMPARED TO ACTIVE CONTROL, THE EFFECT DECREASED TO G = 0.13 (95% CI: -0.18-0.43). NO RCT REPORTED ON SAFETY, ONLY TWO STUDIES REPORTED ON ACADEMIC ACHIEVEMENT, MOST STUDIES HAD A HIGH RISK OF BIAS. CONCLUSIONS: MOST STUDIES WERE OF POOR QUALITY AND RESULTS SHOULD BE INTERPRETED WITH CAUTION. OVERALL MODERATE EFFECTS WERE FOUND WHICH DECREASED SUBSTANTIALLY WHEN INTERVENTIONS WERE COMPARED TO ACTIVE CONTROL. IT IS UNCLEAR WHETHER MEDITATION, YOGA OR MINDFULNESS AFFECT ACADEMIC ACHIEVEMENT OR AFFECT HAVE ANY NEGATIVE SIDE EFFECTS. 2019 17 2118 46 THE EFFECT OF YOGA PRACTICE ON GLYCEMIC CONTROL AND OTHER HEALTH PARAMETERS IN THE PREDIABETIC STATE: A SYSTEMATIC REVIEW AND META-ANALYSIS. A SYSTEMATIC REVIEW AND META-ANALYSIS WAS CONDUCTED TO INVESTIGATE THE EFFECTS OF YOGA ON GLYCEMIC CONTROL, LIPID PROFILES, BODY COMPOSITION AND BLOOD PRESSURE IN PEOPLE IN THE PRE-DIABETIC STATE. STUDIES ON THE EFFECTIVENESS OF YOGA ON POPULATION GROUPS UNDER HIGH RISK FOR DIABETES, CALLED PREDIABETIC OR SUFFERING FROM METABOLIC SYNDROMES WERE EXTRACTED FROM A THOROUGH SEARCH OF PUBMED, SCOPUS, COCHRANE LIBRARY, EBSCO AND INDMED DATABASES. BOTH RANDOMISED CONTROLLED TRIAL (RCT) AND NON-RCT STUDIES WERE INCLUDED IN THE SYSTEMATIC REVIEW AND META-ANALYSIS. STUDIES PUBLISHED BETWEEN JAN 2002 AND DEC 2018 WERE INCLUDED. STUDIES WERE CONSIDERED FOR EVALUATION IF THEY INVESTIGATED A YOGA INTERVENTION TO PREVENT T2DM, AGAINST A CONTROL GROUP, WHILE ALSO REPORTING GLYCEMIC CONTROL AND OTHER HEALTH PARAMETERS OF T2DM MANAGEMENT. SUMMARY EFFECT SIZES AND 95% CONFIDENCE INTERVALS (CI) WERE CALCULATED USING THE COMPREHENSIVE META-ANALYSIS SOFTWARE IN ADDITION TO PUBLICATION BIAS. OF THE 46,500 IDENTIFIED STUDIES, 14 STUDIES WITH 834 PARTICIPANTS OF WHOM WERE 50% WOMEN, WERE FOUND TO BE ELIGIBLE FOR INCLUSION IN OUR SYSTEMATIC REVIEW. OUR QUANTITATIVE SYNTHESIS INCLUDED 12 RANDOMIZED CONTROL TRIALS AND 2 NON-RANDOMIZED CONTROL TRIALS, WITH THE FOLLOW-UP PERIOD RANGING FROM 4 TO 52 WEEKS. COMPARED TO CONTROLS, YOGA INTERVENTION IMPROVED FASTING BLOOD GLUCOSE (FBG) [STANDARD MEAN DIFFERENCE (SMD -0.064 MG/DL (95% CI -0.201 TO 0.074)]; LOW DENSITY LIPOPROTEIN (LDL) [SMD-0.090 MG/DL (95% CI -0.270 TO 0.090)]; TRIGLYCERIDES [SMD -0.148 MG/DL (95% CI -0.285 TO -0.012)]; TOTAL CHOLESTEROL [SMD -0.058 MG/DL (95% CI -0.220 TO 0.104)] AND SYSTOLIC BLOOD PRESSURE [SMD -0.058 MM HG (95% CI -0.168 TO 0.053)]. THIS META-ANALYSIS UNCOVERED CLINICALLY IMPROVED EFFECTS OF YOGA INTERVENTION ON GLYCEMIC CONTROL, LIPID PROFILES AND OTHER PARAMETERS OF T2DM MANAGEMENT IN PREDIABETIC POPULATION. THESE RESULTS SUGGEST THAT YOGA INTERVENTION MAY BE CONSIDERED AS A COMPREHENSIVE AND ALTERNATIVE APPROACH TO PREVENTING T2DM. FURTHER ADEQUATELY POWERED, WELL DESIGNED RCTS ARE NEEDED TO SUPPORT OUR FINDINGS AND INVESTIGATE THE LONG-TERM EFFECTS OF YOGA IN T2DM PATIENTS. 2019 18 1108 30 EFFECTS OF YOGA-BASED INTERVENTIONS ON CANCER-ASSOCIATED COGNITIVE DECLINE: A SYSTEMATIC REVIEW. PURPOSE OF REVIEW: TO SUMMARIZE AND EVALUATE EVIDENCE AVAILABLE ON THE EFFECTS OF YOGA ON CANCER-ASSOCIATED COGNITIVE DECLINE (CACD). RECENT FINDINGS: A SYSTEMATIC REVIEW WAS CONDUCTED USING FOUR DATABASES OF ARTICLES PUBLISHED BEFORE JANUARY 1, 2020. TEN ARTICLES MET THE INCLUSION CRITERIA (SIX RANDOMIZED CONTROLLED TRIALS, TWO SINGLE-ARM STUDIES, ONE NON-RANDOMIZED CONTROLLED TRIAL, AND ONE CASE SERIES STUDY). STUDIES WERE PREDOMINANTLY CONDUCTED WITH BREAST CANCER PATIENTS USING LOW-INTENSITY HATHA YOGA PROGRAMS. OF THE 10 ARTICLES, FIVE REPORTED SOME POSITIVE EFFECTS ON CACD, BUT SIGNIFICANT BIASES WERE POSSIBLE DUE TO DESIGN SHORTCOMINGS. COHEN'S D EFFECT SIZES RANGED FROM |0.03| TO |0.74|. THE EVIDENCE TO DATE IS INSUFFICIENT TO SUGGEST THAT YOGA IS BENEFICIAL FOR ATTENUATING CACD. MORE RIGOROUS TRIALS CONTROLLING FOR NON-SPECIFIC FACTORS ARE WARRANTED. THE FIELD WOULD ALSO BENEFIT FROM EXAMINING SELF-DELIVERED MODES OF YOGA FOR TREATING CACD IN VARIOUS CANCER POPULATIONS TO ENHANCE PRACTICE SUSTAINABILITY AND GENERALIZABILITY. 2020 19 205 36 A REVIEW ON ROLE OF YOGA IN THE MANAGEMENT OF PATIENTS WITH CARDIAC ARRHYTHMIAS. EVIDENCE SUGGESTS THAT YOGA IS SAFE AND EFFECTIVE IN IMPROVING VARIOUS RISK FACTORS, QUALITY OF LIFE (QOL), AND PSYCHOLOGICAL BURDEN THAT IS RELATED TO ARRHYTHMIA. HOWEVER, THIS IS THE FIRST-EVER SYSTEMATIC REVIEW PERFORMED TO REPORT THE ROLE OF YOGA IN ARRHYTHMIA. WE HAVE PERFORMED A LITERATURE SEARCH USING COCHRANE LIBRARY, MEDLINE/PUBMED, WEB OF SCIENCE CORE COLLECTION, AND INDMED ELECTRONIC DATABASES UP TO 3, JANUARY 2018. OF 240 ARTICLES, 6 POTENTIALLY ELIGIBLE ARTICLES WERE IDENTIFIED AND INCLUDED IN THE REVIEW. RESULTS SHOWED THAT YOGA COULD BE CONSIDERED AN EFFICIENT ADJUVANT IN REDUCING ARRHYTHMIA (PAROXYSMAL ATRIAL FIBRILLATION, VENTRICULAR TACHYARRHYTHMIA, AND PALPITATION) RELATED HEALTH PROBLEMS; BLOOD PRESSURE, HEART RATE, DEPRESSION AND ANXIETY SCORES; AND IN IMPROVING HEALTH-RELATED QOL OF ARRHYTHMIA PATIENTS. HOWEVER, THERE IS A LACK OF RANDOMIZED CONTROLLED TRIALS AND A CLEAR MECHANISM BEHIND THE EFFECT OF YOGA; STUDIES HAD RELATIVELY A SMALL SAMPLE SIZE AND DIFFERENT YOGA PROTOCOLS. 2021 20 1058 47 EFFECTS OF YOGA ON EATING DISORDERS-A SYSTEMATIC REVIEW. BACKGROUND: THE QUESTION OF WHETHER YOGA PRACTICE AMELIORATES OR EVEN AGGRAVATES EATING DISORDERS IS CURRENTLY UNDER DEBATE. THE AIM OF THIS REVIEW WAS TO SYSTEMATICALLY ASSESS AND THE EFFECTIVENESS AND SAFETY OF YOGA IN PATIENTS WITH EATING DISORDERS. METHODS: MEDLINE/PUBMED, PSYCINFO, AND THE PSYCHOLOGICAL AND BEHAVIORAL SCIENCE COLLECTION WERE SCREENED THROUGH JULY 2018 FOR RANDOMIZED CONTROLLED TRIALS, NON-RANDOMIZED CONTROLLED TRIALS AND LONGITUDINAL OBSERVATIONAL STUDIES ON YOGA FOR PATIENTS WITH EATING DISORDERS AND OTHER INDIVIDUALS WITH DISORDERED EATING AND/OR BODY DISSATISFACTION. RISK OF BIAS WAS ASSESSED USING THE COCHRANE RISK OF BIAS TOOL AND THE NEWCASTLE-OTTAWA QUALITY ASSESSMENT SCALE. RESULTS: EIGHT RANDOMIZED TRIALS AND FOUR UNCONTROLLED TRIALS INVOLVING A TOTAL OF 495 PARTICIPANTS WERE INCLUDED. RISK OF BIAS WAS MIXED. COMPARING YOGA TO UNTREATED CONTROL GROUPS, EFFECT SIZES RANGED FROM NEGLIGIBLE EFFECTS OF D=0.02 TO VERY LARGE EFFECTS OF D=2.15. HOWEVER, MOST EFFECTS WERE SMALL TO MODERATELY SIZED AND IN MOST CASES NOT SIGNIFICANT. NO SAFETY-RELATED DATA WERE REPORTED. CONCLUSIONS: THERE IS LIMITED EVIDENCE ON THE EFFECTIVENESS AND SAFETY OF YOGA IN PATIENTS WITH EATING DISORDERS. YOGA CAN BE PRELIMINARILY CONSIDERED AS AN ADDITIONAL TREATMENT OPTION IN MULTIMODAL PSYCHIATRIC TREATMENT PROGRAMS. 2019